Little FDA oversight of Chinese, Indian drugs despite deaths

06/17/2007 | Washington Post, The · NYTimes.com

Cheaper drugs and ingredients from China and India are becoming an increasing part of U.S. sales of generics and over-the-counter drugs without FDA oversight. The agency rarely conducts quality-control inspections in the two countries, even after an ingredient in a Chinese drug caused dozens of deaths in Haiti a decade ago and again recently in Panama.

View Full Article in:

Washington Post, The · NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN